The first interpretation gains some preclinical support from the fact that orexin-tTA; TetO DTA mice removed from doxycycline at birth have far less cataplexy in adulthood than mice removed from doxycycline later (Tabuchi et al., 2014). The gene discussed is HCRT; the disease is Cataplexy.